Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-27

FDA Approved: BUMETANIDE — Original Application (Advagen Pharma Limited)

View source ↗

Summary

FDA approved Advagen Pharma Limited's original ANDA for bumetanide, a loop diuretic used to treat edema associated with congestive heart failure, liver cirrhosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUMETANIDE (bumetanide)

Snippet

ORIG AP for BUMETANIDE (BUMETANIDE)